MYBPC3 is the most prevalent disease gene in hypertrophic cardiomyopathy.
Current knowledge regarding the pathomechanisms involved is discussed.
An overview of cMyBP-C posttranslational modifications and their function is given.
MYBPC3-targeting therapeutic strategies are emphasized.